EA033537B1 - Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью - Google Patents

Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью

Info

Publication number
EA033537B1
EA033537B1 EA201591560A EA201591560A EA033537B1 EA 033537 B1 EA033537 B1 EA 033537B1 EA 201591560 A EA201591560 A EA 201591560A EA 201591560 A EA201591560 A EA 201591560A EA 033537 B1 EA033537 B1 EA 033537B1
Authority
EA
Eurasian Patent Office
Prior art keywords
lactic acid
composition
poly
glycolic acid
acid
Prior art date
Application number
EA201591560A
Other languages
English (en)
Russian (ru)
Other versions
EA201591560A1 (ru
Inventor
Jeremy C Wright
Wilma Tamraz
John J Leonard
John W Gibson
Keith E Branham
Stefania Sjobeck
Brooks Boyd
Christopher M Rubino
Original Assignee
Durect Corp
Zogenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Durect Corp, Zogenix Inc filed Critical Durect Corp
Publication of EA201591560A1 publication Critical patent/EA201591560A1/ru
Publication of EA033537B1 publication Critical patent/EA033537B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2033—Spring-loaded one-shot injectors with or without automatic needle insertion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2046—Media being expelled from injector by gas generation, e.g. explosive charge
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8206—Internal energy supply devices battery-operated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
EA201591560A 2013-03-11 2014-03-11 Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью EA033537B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361776336P 2013-03-11 2013-03-11
US201361798874P 2013-03-15 2013-03-15
US201361824827P 2013-05-17 2013-05-17
PCT/US2014/023397 WO2014164754A1 (en) 2013-03-11 2014-03-11 Injectable controlled release composition comprising high viscosity liquid carrier

Publications (2)

Publication Number Publication Date
EA201591560A1 EA201591560A1 (ru) 2016-07-29
EA033537B1 true EA033537B1 (ru) 2019-10-31

Family

ID=50439501

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591560A EA033537B1 (ru) 2013-03-11 2014-03-11 Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью

Country Status (10)

Country Link
US (5) US9737605B2 (https=)
EP (1) EP2986278A1 (https=)
JP (2) JP2016512523A (https=)
CN (3) CN109602692B (https=)
AU (2) AU2014249008B2 (https=)
BR (1) BR112015022023B1 (https=)
CA (1) CA2903769A1 (https=)
EA (1) EA033537B1 (https=)
HK (1) HK1220628A1 (https=)
WO (1) WO2014164754A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
ES2562878T3 (es) 2007-05-25 2016-03-08 Indivior Uk Limited Formulaciones de liberación sostenida de compuestos de risperidona
EP2782590A4 (en) * 2011-11-23 2016-08-03 Durect Corp BIODEGRADABLE AND MEDIUM-RADIATED STERILIZED MEDICAMENTAL COMPOSITIONS
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
EA033537B1 (ru) 2013-03-11 2019-10-31 Durect Corp Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
CN104007070B (zh) * 2014-06-19 2015-04-15 中国石油大学(华东) 用于矿物样品检测的自动观测装置
GB201522764D0 (en) * 2015-12-23 2016-02-03 Nucana Biomed Ltd Formulations of phosphate derivatives
US10682340B2 (en) 2016-06-30 2020-06-16 Durect Corporation Depot formulations
US10668011B2 (en) * 2016-06-30 2020-06-02 Durect Corporation Depot formulations
CN107811967B (zh) * 2016-09-09 2021-08-24 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) 抗寄生虫药物原位固化缓释注射剂及其制备方法
WO2018172850A1 (en) 2017-03-20 2018-09-27 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulaitons
US10806789B2 (en) 2017-05-12 2020-10-20 The LIV Group Inc. Composition for enhanced absorption of supplements
BR112020011189A2 (pt) 2017-12-05 2020-11-17 Sunovion Pharmaceuticals Inc. misturas não racêmicas e usos das mesmas
KR20200110317A (ko) 2017-12-05 2020-09-23 선오비온 파마슈티컬스 인코포레이티드 결정형 및 이의 제조 방법
CA3142355A1 (en) 2019-06-04 2020-12-10 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof
US20220257619A1 (en) * 2019-07-18 2022-08-18 Gilead Sciences, Inc. Long-acting formulations of tenofovir alafenamide
US20220265830A1 (en) * 2019-07-18 2022-08-25 Durect Corporation Long-acting formulations and vehicles
MX2022003051A (es) * 2019-09-13 2022-06-14 Medincell S A Formulaciones para la administracion de farmacos.
US20210292406A1 (en) * 2020-03-18 2021-09-23 Flow Pharma, Inc. Controlled release of antibodies to modulate cytokines
CN113349829B (zh) * 2021-04-27 2022-07-26 四川大学华西医院 一种肿瘤积液取样送检装置
CN117618336B (zh) * 2024-01-26 2024-04-12 山东齐都药业有限公司 K-5a2原位凝胶制剂及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013913A2 (en) * 1997-09-15 1999-03-25 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
US20040101557A1 (en) * 1995-06-07 2004-05-27 Gibson John W. High viscosity liquid controlled delivery system and medical or surgical device
WO2005070332A1 (en) * 2004-01-12 2005-08-04 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
US20080287464A1 (en) * 2007-05-18 2008-11-20 Wright Jeremy C Depot Formulations
WO2012074883A1 (en) * 2010-11-24 2012-06-07 Durect Corporation Biodegradable drug delivery composition

Family Cites Families (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3859996A (en) 1973-07-18 1975-01-14 Mizzy Inc Multi-dose injector
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4421508A (en) 1981-02-24 1983-12-20 Cohen Edgar C Vacuum-compression injector
DE3115376A1 (de) 1981-04-16 1982-12-16 Hoechst Ag, 6000 Frankfurt Nadelloses injektionsgeraet
DE3115375A1 (de) 1981-04-16 1982-11-11 Hoechst Ag, 6000 Frankfurt Kolbenpumpe fuer nadellose injektionsgeraete
US4530840A (en) 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
US4906474A (en) 1983-03-22 1990-03-06 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4725442A (en) 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
HU186718B (en) 1983-06-29 1985-09-30 Radelkis Electrokemiai Automatic needleless syringe operable by cardox cylinder suitable for personal giving injection e.g. insulin
US4891225A (en) 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4913699A (en) 1988-03-14 1990-04-03 Parsons James S Disposable needleless injection system
EP0347190A1 (en) 1988-06-14 1989-12-20 Vci Corporation Needleless vacuum-compression injector
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
AU6550990A (en) 1989-11-09 1991-05-16 Bioject, Inc. Needleless hypodermic injection device
JPH0456736A (ja) 1990-06-22 1992-02-24 Ngk Insulators Ltd 金属溶湯用フィルターカートリッジ
US5149543A (en) 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
WO1992008508A1 (en) 1990-11-09 1992-05-29 Sy-Quest International Limited Needleless hypodermic jet injector device
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
JP3145742B2 (ja) 1991-09-19 2001-03-12 日東電工株式会社 ゴム系感圧性接着剤とその接着シ―ト
KR0170358B1 (ko) 1991-10-22 1999-05-01 . 굴절률 분포형 광학 수지 재료와 그 제조 방법 및 광전송체
DE69327542T2 (de) 1992-11-17 2000-07-06 Yoshitomi Pharmaceutical Industries, Ltd. Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung
NZ260909A (en) 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
ATE197904T1 (de) 1993-07-31 2000-12-15 Weston Medical Ltd Nadelloser injektor
US5643605A (en) 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
EP2283821A1 (en) 1993-11-19 2011-02-16 Alkermes, Inc. Preparation of biodegradable microparticles containing a biologically active agent
US6681810B2 (en) 1994-12-20 2004-01-27 Aradigm Corporation Filling device for a needleless injector cartridge
GB9425642D0 (en) 1994-12-20 1995-02-22 Weston Medical Ltd Filling device
GB9504878D0 (en) 1995-03-10 1995-04-26 Weston Medical Ltd Viscously coupled actuator
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
AU715468B2 (en) 1995-06-22 2000-02-03 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
GB9525757D0 (en) 1995-12-16 1996-02-14 Weston Medical Ltd Needleless injector drug capsule and filling method
GB9602605D0 (en) 1996-02-09 1996-04-10 Weston Medical Ltd Injection aid
EP0892736B1 (en) 1996-04-02 2000-08-30 Weston Medical Limited Method of filling a drug capsule and article produced thereby
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
ATE357218T1 (de) 1996-05-07 2007-04-15 Alkermes Inc Micropartikel
JP4346696B2 (ja) 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
NL1004059C2 (nl) 1996-09-18 1998-03-19 Plastic Moulding Appliances B Samenstel van houder en breeksluiting en werkwijze voor de vervaardiging daarvan.
HUP0000436A3 (en) 1996-09-25 2000-07-28 Weston Medical Ltd Eye Method and apparatus for making an article from a formable material
JP4642946B2 (ja) 1996-12-20 2011-03-02 アルザ コーポレイション ゲル組成物および方法
US6258059B1 (en) 1997-02-06 2001-07-10 Weston Medical Limited Injection aid
US6179583B1 (en) 1997-02-25 2001-01-30 Weston Medical Limited Metered fluid delivery device
US6733767B2 (en) 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
US7208011B2 (en) 2001-08-20 2007-04-24 Conor Medsystems, Inc. Implantable medical device with drug filled holes
GB9818110D0 (en) 1998-08-19 1998-10-14 Weston Medical Ltd Needleless injectors and other devices
US6143314A (en) 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
ATE355824T1 (de) 2000-01-11 2007-03-15 Roland Bodmeier Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
NZ523385A (en) 2000-06-28 2005-09-30 Atul J Biodegradable vehicles and BAS-loaded delivery systems for use as biodegradable fillers and/or spacers, e.g. artificial skin
DE10035889A1 (de) 2000-07-24 2002-02-14 Lohmann Therapie Syst Lts Medizinischer Haftkleber mit einem Gehalt an Zucker-Estern
DE10044545A1 (de) 2000-09-05 2002-04-04 Roland Bodmeier Retardpartikeldispersion
EP1335704A2 (en) 2000-11-16 2003-08-20 Durect Corporation Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
GB0102386D0 (en) 2001-01-31 2001-03-14 Weston Medical Ltd Method for filling needless injector capsules
ATE427760T1 (de) 2001-02-23 2009-04-15 Genentech Inc Erodierbare polymere zur injektion
US20040018238A1 (en) 2001-02-26 2004-01-29 Shukla Atul J Biodegradable vehicles and delivery systems of biolgically active substances
EP1379197A4 (en) 2001-03-23 2009-06-03 Durect Corp DISPOSAL OF MEDICINAL PRODUCTS OF DELAYED RELEASE DEVICES IMPLANTED IN MYOKARD TISSUE OR PER ICARDROOM
GB0112324D0 (en) 2001-05-21 2001-07-11 Croda Int Plc Compounds
JP2003063954A (ja) 2001-08-24 2003-03-05 Saitama Daiichi Seiyaku Kk リザーバー型貼付剤
GB0125506D0 (en) 2001-10-24 2001-12-12 Weston Medical Ltd Needle free injection method and apparatus
EP1446101B1 (en) 2001-11-14 2011-03-23 Durect Corporation Catheter injectable depot compositions and uses thereof
DE60239952D1 (de) 2001-11-14 2011-06-16 Durect Corp Injizierbare depotzusammensetzungen und deren verwendung
JP5170935B2 (ja) 2001-11-14 2013-03-27 デュレクト コーポレーション 注入可能なデポー組成物
GB0127942D0 (en) 2001-11-21 2002-01-16 Weston Medical Ltd Needleless injector drug capsule and a method for filing thereof
US20040258731A1 (en) 2001-11-21 2004-12-23 Tsuyoshi Shimoboji Preparation approriate for cartilage tissue formation
GB0206560D0 (en) 2002-03-20 2002-05-01 Glaxo Group Ltd Novel device
MY139059A (en) 2002-06-24 2009-08-28 Alza Corp Reusable, spring driven autoinjector
US20040109893A1 (en) 2002-06-25 2004-06-10 Guohua Chen Sustained release dosage forms of anesthetics for pain management
AR039729A1 (es) 2002-06-25 2005-03-09 Alza Corp Formulaciones de deposito de corta duracion
CN1684663A (zh) 2002-07-31 2005-10-19 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
WO2004011065A1 (en) 2002-07-31 2004-02-05 Alza Corporation Injection device providing automatic needle retraction
EP1556091A1 (en) 2002-10-04 2005-07-27 Elan Pharma International Limited Gamma irradiation of solid nanoparticulate active agents
RU2355385C2 (ru) 2002-11-06 2009-05-20 Алза Корпорейшн Композиции пролонгированного действия с контролируемым высвобождением
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
US7231945B2 (en) 2002-12-18 2007-06-19 Zogenix, Inc. Method of proof testing glass
WO2004094414A1 (en) 2003-04-22 2004-11-04 Synthon B.V. Water soluble salts of risperidone
CA2527664A1 (en) 2003-05-30 2004-12-16 Alza Corporation Implantable elastomeric depot compositions, uses thereof and method of manufacturing
JP2007504256A (ja) 2003-09-01 2007-03-01 メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド 生物活性剤の送達のための組成物及び方法
MY158342A (en) 2003-11-14 2016-09-30 Novartis Ag Pharmaceutical composition
US20050281879A1 (en) 2003-11-14 2005-12-22 Guohua Chen Excipients in drug delivery vehicles
US20050106214A1 (en) 2003-11-14 2005-05-19 Guohua Chen Excipients in drug delivery vehicles
EP1689465A4 (en) * 2003-12-05 2011-10-12 Zogenix Inc DEVICE FOR DELIVERY OF A NEEDLELESS INJECTOR USED FOR DRUG DELIVERY
US20100016267A1 (en) 2004-03-15 2010-01-21 Felix Theeuwes Pharmaceutical compositions for administraton to a sinus
IS7290A (is) 2004-05-28 2005-11-29 Actavis Group Lyfjasamsetningar sem innihalda risperidone
GB0412866D0 (en) 2004-06-09 2004-07-14 Novartis Ag Organic compounds
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
CN103071209A (zh) 2005-11-17 2013-05-01 周吉尼克斯股份有限公司 用无针注射递送粘稠制剂
WO2007084460A2 (en) 2006-01-18 2007-07-26 Qps, Llc Pharmaceutical compositions with enhanced stability
DK3660073T3 (da) 2007-02-15 2023-09-18 Tolmar International Ltd Poly(lactid-co-glycolid) med lav sprængning
CA2682848A1 (en) 2007-04-03 2008-10-16 Trimeris, Inc. Novel formulations for delivery of antiviral peptide therapeutics
ES2562878T3 (es) 2007-05-25 2016-03-08 Indivior Uk Limited Formulaciones de liberación sostenida de compuestos de risperidona
EP2244679A4 (en) 2008-02-08 2013-10-09 Qps Llc NON-POLYMERIC COMPOSITIONS FOR CONTROLLED MEDICINAL PRODUCTION
WO2009148580A2 (en) * 2008-06-03 2009-12-10 Qlt Usa, Inc. Controlled release copolymer formulation with improved release kinetics
PL2394663T3 (pl) 2010-05-31 2022-02-21 Laboratorios Farmaceuticos Rovi, S.A. Kompozycje do wstrzykiwania implantów biodegradowalnych in-situ
PL2394664T3 (pl) 2010-05-31 2016-12-30 Preparat przeciwpsychotyczny do wstrzykiwań o przedłużonym uwalnianiu
PT2529756T (pt) 2011-05-31 2021-07-28 Farm Rovi Lab Sa Formulação de implante de risperidona e/ou paliperidona
EA033537B1 (ru) 2013-03-11 2019-10-31 Durect Corp Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040101557A1 (en) * 1995-06-07 2004-05-27 Gibson John W. High viscosity liquid controlled delivery system and medical or surgical device
WO1999013913A2 (en) * 1997-09-15 1999-03-25 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
WO2005070332A1 (en) * 2004-01-12 2005-08-04 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
US20080287464A1 (en) * 2007-05-18 2008-11-20 Wright Jeremy C Depot Formulations
WO2012074883A1 (en) * 2010-11-24 2012-06-07 Durect Corporation Biodegradable drug delivery composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LU, Y. TANG, X. CUI, Y. ZHANG, Y. QIN, F. LU, X.: "In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS., ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM., NL, vol. 68, no. 2, 10 January 2008 (2008-01-10), NL, pages 422 - 429, XP022415436, ISSN: 0939-6411, DOI: 10.1016/j.ejpb.2007.05.016 *

Also Published As

Publication number Publication date
JP2016512523A (ja) 2016-04-28
CN109602692A (zh) 2019-04-12
AU2019201172A1 (en) 2019-03-07
BR112015022023B1 (pt) 2022-12-06
AU2014249008A1 (en) 2015-10-01
US9737605B2 (en) 2017-08-22
JP6758577B2 (ja) 2020-09-23
US20210015924A1 (en) 2021-01-21
AU2014249008B2 (en) 2018-12-06
CN109602692B (zh) 2022-11-04
JP2019048884A (ja) 2019-03-28
US10226532B2 (en) 2019-03-12
CA2903769A1 (en) 2014-10-09
US20160038596A1 (en) 2016-02-11
HK1220628A1 (zh) 2017-05-12
CN115804749A (zh) 2023-03-17
EP2986278A1 (en) 2016-02-24
EA201591560A1 (ru) 2016-07-29
US11285217B2 (en) 2022-03-29
AU2019201172B2 (en) 2020-07-16
BR112015022023A2 (pt) 2020-10-20
WO2014164754A1 (en) 2014-10-09
CN105163719A (zh) 2015-12-16
US20190255179A1 (en) 2019-08-22
US20220280646A1 (en) 2022-09-08
US20180036412A1 (en) 2018-02-08
CN105163719B (zh) 2019-03-08

Similar Documents

Publication Publication Date Title
EA033537B1 (ru) Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью
Ding et al. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Alexander et al. Poly (ethylene glycol)–poly (lactic-co-glycolic acid) based thermosensitive injectable hydrogels for biomedical applications
MX2018001499A (es) Sistema para la entrega de polimeros liquidos para la administracion prolongada de farmacos.
JP2013253101A5 (https=)
HRP20250087T1 (hr) Farmaceutski pripravak
AU2018309068A8 (en) Formulations comprising a nucleic acid in a high concentration
WO2015038818A3 (en) Liquid protein formulations containing viscosity-lowering agents
MX2013003892A (es) Composicion farmaceutica liquida para el suministro de ingredientes activos.
WO2013036309A3 (en) Sustained release formulations for delivery of proteins to the eye and methods of preparing same
UA111162C2 (uk) Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
WO2008143992A3 (en) Improved depot formulations
WO2015164272A3 (en) Long-acting polymeric delivery systems
CO7151506A2 (es) Formulación de fármaco de liberación retardada
AR086660A1 (es) Composicion para el tratamiento de diabetes que comprende un conjugado de insulina de accion prolongada y conjugado de un peptido insulinotropico de accion prolongada
SA517381298B1 (ar) تركيبة صيدلية بثبات محسن
NZ629730A (en) Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
PH12014501937A1 (en) Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative
NZ740615A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
SV2011003907A (es) Composiciones antimicrobianas
BR112015017246A8 (pt) composição farmacêutica aquosa, seu uso e seringa
BR112012017556A2 (pt) formulações de torta liofilizada
WO2011126839A3 (en) Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
AR105223A1 (es) Compuestos químicos
BR112018075984A2 (pt) composição de distribuição de fármaco parenteral para liberação sustentada

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment